Axon Vision Income Statement

Financials in millions ILS. Fiscal year is January - December.

Millions ILS. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Revenue	17.4	15.87	10.51	8.41
Revenue Growth (YoY)	9.64%	50.97%	25.02%	-
Cost of Revenue	8.52	8.47	5.89	4.99
Gross Profit	8.88	7.39	4.62	3.41
Selling, General & Admin	12.09	4.85	3.33	1.96
Research & Development	5.62	4.36	2.25	1.49
Other Operating Expenses	-	-	-	0.04
Operating Expenses	17.71	9.2	5.58	3.5
Operating Income	-8.84	-1.81	-0.96	-0.08
Interest Expense	-1.02	-0.76	-0.84	-0.76
Interest & Investment Income	-	0.02	-	-
Currency Exchange Gain (Loss)	-	-0	0.04	0.08
Other Non Operating Income (Expenses)	0.34	-	-	-
EBT Excluding Unusual Items	-9.51	-2.55	-1.75	-0.76
Other Unusual Items	-	-0.5	-	-
Pretax Income	-9.51	-3.05	-1.75	-0.76
Income Tax Expense	-0.08	-0.17	-	-
Net Income	-9.43	-2.88	-1.75	-0.76
Net Income to Common	-9.43	-2.88	-1.75	-0.76
Shares Outstanding (Basic)	14	0	0	0
Shares Outstanding (Diluted)	14	0	0	0
Shares Change (YoY)	33931.17%	0.15%	0.07%	-
EPS (Basic)	-0.69	-71.65	-43.70	-18.92
EPS (Diluted)	-0.69	-71.65	-43.70	-18.92
Free Cash Flow	-9.01	-2.28	0.98	0.21
Free Cash Flow Per Share	-0.66	-56.73	24.37	5.27
Gross Margin	51.04%	46.60%	43.97%	40.59%
Operating Margin	-50.79%	-11.41%	-9.12%	-1.00%
Profit Margin	-54.21%	-18.13%	-16.67%	-9.02%
Free Cash Flow Margin	-51.82%	-14.36%	9.30%	2.51%
EBITDA	-8.4	-1.74	-0.87	0.04
EBITDA Margin	-48.30%	-10.94%	-8.27%	0.49%
D&A For EBITDA	0.43	0.07	0.09	0.13
EBIT	-8.84	-1.81	-0.96	-0.08
EBIT Margin	-50.79%	-11.41%	-9.12%	-1.00%